2nd line treatment options for hr breast cancer.
Published 5 days ago • 53 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
0:38
standard of care practice in adjuvant hr breast cancer before asco 2023 #oncology #asco2023 #cancer
-
21:03
how to treat hr breast cancer with dr. virginia kaklamani | onc brothers
-
22:12
how to treat her2 breast cancer in 2024 with dr. harold burstein
-
22:01
hr breast cancer management - oncbrothers (rohit & rahul gosain) w/ dr. margaret gatti-mays
-
22:08
breast cancer asco 2024 practice changing highlights - discussion with dr. erika hamilton
-
14:04
her2 positive breast cancer algorithm - oncbrothers (rohit & rahul gosain) w/ dr. erika hamilton
-
20:03
destiny-breast04 study discussion - oncbrothers (rohit and rahul gosain) with dr. shanu modi
-
15:24
breast cancer asco 2022 highlights - oncbrothers (rohit and rahul gosain) with dr. sara tolaney
-
18:44
hr invasive lobular carcinoma management - oncbrothers (rohit & rahul gosain) w/ dr. jason mouabbi
-
17:08
hormone positive breast cancer algorithm - oncbrothers (rohit & rahul gosain) w/ dr. stephanie graff
-
23:51
2022 west oncology conference | precision oncology in hr breast cancer
-
18:38
how to treat triple negative breast cancer | dr. ruth o'regan chair & dr. anna weiss
-
2:17:54
changing treatment landscape in hr her2 abc
-
59:38
what's new and on the horizon for metastatic breast cancer?
-
17:11
emerald lead to the elacestrant fda approval - oncbrothers in discussion w/ dr. virginia kaklamani
-
13:51
esmo 2023 breast cancer highlights – keynote 756, tropion-breast01, keynote 52 | onc brothers
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
8:40
first-line treatment of her2-positive metastatic breast cancer
-
1:07:43
new & supporting data for optimizing therapy in her2 breast cancer | dr. mahtani & dr. schwartzberg